Kjellin M.; Wesslén T.; Löfblad E.; Lennerstrand J.; Lannergård A. The Effect of the First-Generation HCV-Protease Inhibitors Boceprevir and Telaprevir and the Relation to Baseline NS3 Resistance Mutations in Genotype 1: Experience from a Small Swedish Cohort. ujms 2018, 123, 50–56.